| 11th week of 2022 patent applcation highlights part 10 |
| Patent application number | Title | Published |
|---|
| 20220079864 | AQUEOUS COSMETIC | 2022-03-17 |
| 20220079865 | NON-COMEDOGENIC AND NON-ACNEGENIC HAIR AND SCALP CARE FORMULATIONS AND METHOD FOR USE | 2022-03-17 |
| 20220079866 | PIGMENT DYEING COMPOSITION BASED ON A PARTICULAR ACRYLIC POLYMER AND ON SILICONE COPOLYMER, AND DYEING METHOD | 2022-03-17 |
| 20220079867 | OXIDATIVE HAIR CREAM COMPOSITION CONTAINING POLYMERIC COLORANT | 2022-03-17 |
| 20220079868 | OXIDATIVE HAIR CREAM COMPOSITION CONTAINING THIOPHENE AZO COLORANT | 2022-03-17 |
| 20220079869 | COSMETIC COMPOSITIONS COMPRISING SILICONE ELASTOMER | 2022-03-17 |
| 20220079870 | TOPICAL SKINCARE COMPOSITIONS COMPRISING CENTELLA ASIATICA | 2022-03-17 |
| 20220079871 | MICROORGANISMS INHIBITING THE FORMATION OF FOOT MALODOR | 2022-03-17 |
| 20220079872 | NANOPARTICLES COMPRISING TACROLIMUS | 2022-03-17 |
| 20220079873 | TOPICAL COMPOSITIONS AND METHODS OF USE | 2022-03-17 |
| 20220079874 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING THE SAME | 2022-03-17 |
| 20220079875 | IMPLANTABLE DEVICES FOR TREATING HIV | 2022-03-17 |
| 20220079876 | OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR | 2022-03-17 |
| 20220079877 | DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO | 2022-03-17 |
| 20220079878 | Ophthalmic Drug Compositions | 2022-03-17 |
| 20220079879 | EMULSIFIED GEL COMPOSITION | 2022-03-17 |
| 20220079880 | SOLID MICELLAR COMPOSITIONS OF CANNABINOID ACIDS | 2022-03-17 |
| 20220079881 | Orally Administrable Composition | 2022-03-17 |
| 20220079882 | COMPOSITIONS AND METHODS FOR INCREASING THE BIOAVAILABILITY OF ONE OR MORE COMPOUNDS | 2022-03-17 |
| 20220079883 | ELTROMBOPAG CHOLINE DOSAGE FORMS | 2022-03-17 |
| 20220079884 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | 2022-03-17 |
| 20220079885 | EXPANDABLE MICROCAPSULE | 2022-03-17 |
| 20220079886 | METHOD OF PREPARATION OF BIOCOMPATIBLE METAL NANOPARTICLES AND APPLICATIONS THEREOF | 2022-03-17 |
| 20220079887 | TRANSDERMAL THERAPEUTIC SYSTEM WITH DIFFUSION BARRIER | 2022-03-17 |
| 20220079888 | PRE-NATAL BETA-CRYPTOXANTHIN BENEFITS CHILDREN | 2022-03-17 |
| 20220079889 | USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY | 2022-03-17 |
| 20220079890 | METHOD OF MANUFACTURING STABLE EMULSIONS AND COMPOSITIONS CONTAINING THE SAME | 2022-03-17 |
| 20220079891 | COMBINATION THERAPY OF PHOSPHATE BINDERS AND VITAMIN K | 2022-03-17 |
| 20220079892 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2022-03-17 |
| 20220079893 | ANTIMICROBIAL COMPOSITIONS WITH 1,2-ALKANEDIOLS | 2022-03-17 |
| 20220079894 | STABLE PHARMACEUTICAL COMPOSITIONS | 2022-03-17 |
| 20220079895 | COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES | 2022-03-17 |
| 20220079896 | DELAYED RELEASE COMPOSITIONS | 2022-03-17 |
| 20220079897 | METHODS OF TREATMENT | 2022-03-17 |
| 20220079898 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | 2022-03-17 |
| 20220079899 | COMPOSITIONS AND METHODS FOR TREATING OCULAR CONDITIONS | 2022-03-17 |
| 20220079900 | COMPOSITIONS AND METHODS FOR TREATING CARDIAC INJURY | 2022-03-17 |
| 20220079901 | SYNERGISTIC COMBINATIONS OF CAROTENOIDS AND POLYPHENOLS | 2022-03-17 |
| 20220079902 | COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS | 2022-03-17 |
| 20220079903 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ADHESIONS AND ILUES | 2022-03-17 |
| 20220079904 | METHODS AND COMPOSITIONS FOR TREATING CANNABIS USE DISORDER AND MITIGATING CANNABINOID WITHDRAWAL | 2022-03-17 |
| 20220079905 | MAGNETIC RESONANCE IMAGING DRUG CONTAINING DEUTERATED SARCOSINE, AND DIAGNOSTIC METHOD USING SAID DRUG | 2022-03-17 |
| 20220079906 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2022-03-17 |
| 20220079907 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2022-03-17 |
| 20220079908 | DIETARY BUTYRATE FOR TREATING OR PREVENTING AN ALLERGIC DISORDER | 2022-03-17 |
| 20220079909 | Food Supplement For Improving Sports Performance | 2022-03-17 |
| 20220079910 | Cancer Treatment Useing Docetaxel by Controlling Peak Plasma Levels | 2022-03-17 |
| 20220079911 | USES OF PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) INHIBITORS | 2022-03-17 |
| 20220079912 | ANTICANCER FORMULATION | 2022-03-17 |
| 20220079913 | DIHYDROMYRICETIN WITH ANTI-ALCOHOLIC EFFECT | 2022-03-17 |
| 20220079914 | MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES | 2022-03-17 |
| 20220079915 | IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2022-03-17 |
| 20220079916 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | 2022-03-17 |
| 20220079917 | LSD1 INHIBITORS AND MEDICAL USES THEREOF | 2022-03-17 |
| 20220079918 | Therapeutic potential of glycopyrrolate and mexiletine for nervous system injury | 2022-03-17 |
| 20220079919 | LISINOPRIL COMPOSITIONS WITH AN INGESTIBLE EVENT MARKER | 2022-03-17 |
| 20220079920 | PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE, CHLORTHALIDONE, AND AMILORIDE AND APPLICATION THEREOF | 2022-03-17 |
| 20220079921 | SOLID MICRONIZED MELATONIN COMPOSITION | 2022-03-17 |
| 20220079922 | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, HYPEROPIA, ASTIGMATISM, DECREASED STEREOPSIS, AND DECREASED CONTRAST SENSITIVITY | 2022-03-17 |
| 20220079923 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS | 2022-03-17 |
| 20220079924 | GLUCOCORTICOID RECEPTOR MODULATORS | 2022-03-17 |
| 20220079925 | COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES | 2022-03-17 |
| 20220079926 | INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE | 2022-03-17 |
| 20220079927 | NICORANDIL DERIVATIVES | 2022-03-17 |
| 20220079928 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR | 2022-03-17 |
| 20220079929 | USE OF AXITINIB AND ANALOGS THEREOF IN PREPARING BLOOD-BRAIN BARRIER PERMEABILITY REGULATOR | 2022-03-17 |
| 20220079930 | Therapeutic Cancer Immune Modulation by Treatment with mTOR Inhibitors | 2022-03-17 |
| 20220079931 | ESTROGEN RECEPTOR PROTEIN DEGRADERS | 2022-03-17 |
| 20220079932 | NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF | 2022-03-17 |
| 20220079933 | CRENOLANIB FOR TREATING TRK KINASE ASSOCIATED PROLIFERATIVE DISORDERS | 2022-03-17 |
| 20220079934 | CRENOLANIB FOR TREATING PAIN | 2022-03-17 |
| 20220079935 | COMPOUNDS AND TREATMENTS THAT ENHANCE ENTERIC NERVOUS SYSTEM FUNCTION | 2022-03-17 |
| 20220079936 | MULTI-ARM POLYMER PRODRUGS | 2022-03-17 |
| 20220079937 | PHARMACEUTICAL FORMULATION | 2022-03-17 |
| 20220079938 | PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF ALPHA, BETA-UNSATURATED KETONE COMPOUNDS | 2022-03-17 |
| 20220079939 | ARIPIPRAZOLE PRODRUG COMPOSITION | 2022-03-17 |
| 20220079940 | METHODS OF TREATING CANCERS | 2022-03-17 |
| 20220079941 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LOWE SYNDROME | 2022-03-17 |
| 20220079942 | PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS | 2022-03-17 |
| 20220079943 | TARGETED DOSING FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2022-03-17 |
| 20220079944 | 2H-INDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS FOR BRAIN CANCERS AND BRAIN METASTASES | 2022-03-17 |
| 20220079945 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | 2022-03-17 |
| 20220079946 | METHODS OF TREATING NEUROEPITHELIAL TUMORS USING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | 2022-03-17 |
| 20220079947 | COMBINATION THERAPIES | 2022-03-17 |
| 20220079948 | COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING HIV-INFECTION AND/OR A RELATED CLINICAL CONDITION THEREOF | 2022-03-17 |
| 20220079949 | METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS | 2022-03-17 |
| 20220079950 | THERAPEUTIC COMBINATIONS AS ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE | 2022-03-17 |
| 20220079951 | BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD | 2022-03-17 |
| 20220079952 | Uses of Radiation and Benzodiazepine Derivatives in Cancer Therapies | 2022-03-17 |
| 20220079953 | METHODS FOR MANAGEMENT OF WEIGHT | 2022-03-17 |
| 20220079954 | Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk | 2022-03-17 |
| 20220079955 | Testosterone Ester Triglyceride Formulations | 2022-03-17 |
| 20220079956 | MAINTENANCE OF AGING MUSCLE TISSUE | 2022-03-17 |
| 20220079957 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2022-03-17 |
| 20220079958 | COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS | 2022-03-17 |
| 20220079959 | PHARMACEUTICAL COMPOSITIONS OF TORSEMIDE AND USES THEREOF | 2022-03-17 |
| 20220079960 | USE OF P1P DERIVATIVES AS THERAPEUTIC AGENT FOR SEPSIS | 2022-03-17 |
| 20220079961 | NASAL SPRAY FORMULATIONS USING BOTANICALS, STEROIDS ORGANOSILANE QUATERNARIES, POLYOL STABILIZING AGENTS AND NONIONIC SURFACTANT AS ANTIMICROBIALS, ANTIVIRALS AND BIOCIDES TO PROTECT THE CELLS, SKIN AND HAIR OF NASAL PASSAGES | 2022-03-17 |
| 20220079962 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | 2022-03-17 |
| 20220079963 | A NUTRITIONAL COMPOSITION COMPRISING 2'-FUCOSYLLACTOSE (2' FL) TO IMPROVE THE GASTROINTESTINAL BARRIER | 2022-03-17 |
